Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 3/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.40 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.40 |
| ▸ | TDP2 | O95551 | 2/20 | 0.39 |
| ▸ | DHODH | Q02127 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13727858 | 0.99 | PDK2 (0.48) | PDK2CYP19A1CYP11B1CYP17A1CYP11B2 | |
| SCHEMBL13726215 | 0.93 | PDK2 (0.49) | PDK2CYP19A1CYP11B1CYP17A1CYP11B2 | |
| SCHEMBL13728162 | 0.91 | PDK2 (0.49) | PDK2CYP19A1CYP11B1CYP17A1CYP11B2 | |
| SCHEMBL13727891 | 0.89 | PDK2 (0.48) | PDK2CYP19A1CYP11B1CYP17A1CYP11B2 | |
| SCHEMBL13728438 | 0.89 | PDK2 (0.49) | PDK2CYP19A1CYP11B1CYP17A1CYP11B2 | |
| SCHEMBL13727269 | 0.88 | PDK2 (0.48) | PDK2CYP19A1CYP11B1CYP17A1CYP11B2 | |
| SCHEMBL13726661 | 0.88 | PDK2 (0.51) | PDK2CYP19A1CYP11B1CYP17A1CYP11B2 | |
| SCHEMBL13726536 | 0.88 | PDK2 (0.45) | PDK2ALDH1A1KDM4EGAAMAPT | |
| SCHEMBL13727268 | 0.88 | PDK2 (0.47) | PDK2DHODHALDH1A1KDM4EMAPT | |
| SCHEMBL13726766 | 0.87 | PDK2 (0.47) | PDK2CYP19A1CYP11B1CYP17A1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586740-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-11-19 | — | — | US | disclosed |
| US-20130049577-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2013-02-28 | — | — | US | disclosed |
| US-20130049577-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2013-02-28 | — | — | US | disclosed |
| US-20090203704-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-08-13 | — | — | US | disclosed |
| US-20090203704-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-08-13 | — | — | US | disclosed |
| EP-2065378-A1 | Quinoxaline derivate, and light-emitting element, light-emitting device, and electronic device using quinoxaline derivative | Semiconductor Energy Laboratory Co, Ltd. (JP) | 2009-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203704-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Quinoxaline Derivative | PDXK, NQO1, PPOX | PDK2 59/4885CYP19A1 3647/4885CYP11B1 2804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.